Enable Biosciences

Enable Biosciences, Inc. is a disease detection company spun off from the University of California, Berkeley, and Stanford University in 2015. The company is developing more sensitive antibody tests for the early detection and treatment of diseases such as HIV and type 1 diabetes. It has currently developed multiple products: testing solutions for celiac disease, food allergies, Lyme disease, and Zika/dengue fever are for research use only; products for type 1 diabetes can be used for both research and clinical diagnosis, and also include some customized assay solutions.